Cargando…

Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD?

BACKGROUND: Brain derived proteins such as 14-3-3, neuron-specific enolase (NSE), S 100b, tau, phosphorylated tau and Aβ(1–42 )were found to be altered in the cerebrospinal fluid (CSF) in Creutzfeldt-Jakob disease (CJD) patients. The pathogenic mechanisms leading to these abnormalities are not known...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boesenberg-Grosse, Constanze, Schulz-Schaeffer, Walter J, Bodemer, Monika, Ciesielczyk, Barbara, Meissner, Bettina, Krasnianski, Anna, Bartl, Mario, Heinemann, Uta, Varges, Daniela, Eigenbrod, Sabina, Kretzschmar, Hans A, Green, Alison, Zerr, Inga
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592107/ https://www.ncbi.nlm.nih.gov/pubmed/16989662 http://dx.doi.org/10.1186/1471-2377-6-35

Ejemplares similares

Doxycycline in early CJD: a double-blinded randomised phase II and observational study
por: Varges, Daniela, et al.
Publicado: (2017)

Progress in CSF biomarker discovery in sCJD
por: Llorens, Franc, et al.
Publicado: (2016)

A proposal of new diagnostic pathway for fatal familial insomnia
por: Krasnianski, A, et al.
Publicado: (2014)

CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD
por: Ermann, Natalia, et al.
Publicado: (2018)

Imaging and CSF analyses effectively distinguish CJD from its mimics
por: Rudge, Peter, et al.
Publicado: (2018)

Characteristic CSF Prion Seeding Efficiency in Humans with Prion Diseases
por: Cramm, Maria, et al.
Publicado: (2014)

Brain microglia were activated in sporadic CJD but almost unchanged in fatal familial insomnia and G114V genetic CJD
por: Shi, Qi, et al.
Publicado: (2013)

High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions
por: Franceschini, Alessia, et al.
Publicado: (2017)

NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression
por: Mengel, David, et al.
Publicado: (2021)

Mad Cows and CJD: A Physicist's View of Prion Brain Diseases
por: Morrison, Douglas Robert Ogston
Publicado: (1997)

CJD mimics and chameleons
por: Mead, Simon, et al.
Publicado: (2017)

Blood borne transit of CJD from brain to gut at early stages of infection
por: Radebold, Klaus, et al.
Publicado: (2001)

Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders
por: Singh, Ajay, et al.
Publicado: (2011)

Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients
por: Douet, Jean-Yves, et al.
Publicado: (2021)

Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie
por: Schmitz, Matthias, et al.
Publicado: (2016)

Investigating the Association of ApoE Genotypes with Blood-Brain Barrier Dysfunction Measured by Cerebrospinal Fluid-Serum Albumin Ratio in a Cohort of Patients with Different Types of Dementia
por: Karch, André, et al.
Publicado: (2013)

vCJD risk in the Republic of Ireland
por: Harney, Michael S, et al.
Publicado: (2003)

Familial CJD- A Brief Commentary
por: Chandra, Satish, et al.
Publicado: (2019)

EEG Observations in Probable Sporadic CJD
por: Mundlamurri, Ravindranadh Chowdary, et al.
Publicado: (2020)

The Various Faces of Creutzfeldt-Jakob Disease (CJD); a Case of CJD Presenting as Psychosis in a Middle-Aged Woman
por: Sodiya, Olusegun, et al.
Publicado: (2022)

Application of quantitative DTI metrics in sporadic CJD()
por: Caverzasi, E., et al.
Publicado: (2014)

Variant CJD: 18 years of research and surveillance
por: Diack, Abigail B, et al.
Publicado: (2014)

Sporadic Creutzfeldt–Jakob disease subtype-specific alterations of the brain proteome: Impact on Rab3a recycling
por: Gawinecka, Joanna, et al.
Publicado: (2012)

CSF Biomarkers and Neuropsychological Profiles in Patients with Cerebral Small-Vessel Disease
por: Hermann, Peter, et al.
Publicado: (2014)

Epidemiological evidence of higher susceptibility to vCJD in the young
por: Boëlle, Pierre-Yves, et al.
Publicado: (2004)

Updated projections of future vCJD deaths in the UK
por: Ghani, Azra C, et al.
Publicado: (2003)

Preclinical Detection of Variant CJD and BSE Prions in Blood
por: Lacroux, Caroline, et al.
Publicado: (2014)

Public health risks from subclinical variant CJD
por: Diack, Abigail B., et al.
Publicado: (2017)

Transmissible amyloid protein: evidence from iatrogenic CJD
por: Hu, Mo, et al.
Publicado: (2018)

Variant CJD: Reflections a Quarter of a Century on
por: Ritchie, Diane L., et al.
Publicado: (2021)

Assessing initial MRI reports for suspected CJD patients
por: Jesuthasan, Aaron, et al.
Publicado: (2022)

RNAs in Brain and Heart Diseases †
por: Beis, Dimitris, et al.
Publicado: (2020)

Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis
por: Sanchez-Juan, P., et al.
Publicado: (2007)

Novel mutation of the PRNP gene of a clinical CJD case
por: Kotta, Konstantia, et al.
Publicado: (2006)

RT-QuIC: a new test for sporadic CJD
por: Green, Alison J E
Publicado: (2019)

Regulation of CSF and Brain Tissue Sodium Levels by the Blood-CSF and Blood-Brain Barriers During Migraine
por: Ghaffari, Hamed, et al.
Publicado: (2020)

Elevated E200K Somatic Mutation of the Prion Protein Gene (PRNP) in the Brain Tissues of Patients with Sporadic Creutzfeldt–Jakob Disease (CJD)
por: Won, Sae-Young, et al.
Publicado: (2023)

The management of potential exposures to Cretuzfeld-Jakob Disease (CJD) via endoscopy
por: Iten, A, et al.
Publicado: (2011)

Re-Assessment of PrP(Sc) Distribution in Sporadic and Variant CJD
por: Rubenstein, Richard, et al.
Publicado: (2013)

What Promises the CJD Diagnosis in a Case of Rapidly Progressive Dementia?
por: Aslam, Sana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qokqf1l5d79vhno7rq9thqkk0g